Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsEventsSponsored PodcastsSponsored VideosWebcastsWhitepaperseBooks
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Prashanth Prasad

Advertisement

Articles by Prashanth Prasad

Genetic Testing chart.png

The Personalized Genetic Profile: It’s Time to Align

ByCraig Wylie,Prashanth Prasad
March 1st 2018

Pharmaceutical Executive

Innovations in consumer genetic health are rapidly advancing-and pharma commercial thinking needs to catch up.

Advertisement

Latest Updated Articles

  • Genetic Testing chart.png
    The Personalized Genetic Profile: It’s Time to Align

    March 1st 2018



Advertisement
Advertisement

Trending on PharmExec

1

FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B

2

FDA Grants Ultomiris Accelerated Approval in the U.S. for Adults with Primary Immunoglobulin A Nephropathy

3

CSL Names Deborah Waterhouse as CEO and Manager Director

4

Median Drug Launch Prices Hit $257,000 as Access Barriers Persist, ICER and West Health Report Finds

5

The Therapeutic Areas or Deals That Might Be Negatively Impacted by MFN Deals

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us